Article
Biliary tract cancers: advances in diagnostic and management
23 Jun 2025
Abstract excerpt
Biliary tract cancers (BTCs) are aggressive malignancies associated with poor prognosis and limited treatment options. Advances in precision oncology, notably the identification of recurrent molecular alterations such as fibroblast growth factor receptor 2 (FGFR2) fusions, isocitrate dehydrogenase 1 (IDH1) mutations, ERBB2 amplifications, and v-Raf murine sarcoma viral oncogene homolog B (BRAF) V600E mutations,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
